Altimmune - Company & Market Research Reports

Altimmune is an immunotherapeutic biotechnology company that develops immunotherapeutic products and vaccines to address public health and biodefense needs. It offers NasoVAX, HepTcell, NasoShield and Oncosyn. The company also develops products for use in companion and commercial livestock and offers immunotherapeutic products for various disease indications. The company was founded in 1997 and is based in Gaithersburg, Maryland with operating sites in the UK and France.

From
From
From
From
From
From
Hepatitis B - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis B - Pipeline Review, H1 2018

  • Drug Pipelines
  • 365 Pages
From
From
From
From
From
From
Anthrax - Pipeline Review, H2 2018 - Product Thumbnail Image

Anthrax - Pipeline Review, H2 2018

  • Drug Pipelines
  • 106 Pages
From
Malaria - Pipeline Review, H1 2018 - Product Thumbnail Image

Malaria - Pipeline Review, H1 2018

  • Drug Pipelines
  • 346 Pages
From
From
From
H1N1 infection - Pipeline Insight, 2018 - Product Thumbnail Image

H1N1 infection - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
From
Loading Indicator
adroll